Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16435 | 28391883 | J Clin Lipidol | Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. | 2016 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16443 | 28384519 | J Nutr Biochem | Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. | 2017 | Details |
| A16444 | 28383715 | Nutr Rev | Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. | 2017 | Details |
| A16449 | 28381740 | Intern Med | The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16451 | 28381382 | Hepatobiliary Pancreat Dis Int | The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population. | 2017 | Details |
| A16453 | 28377802 | Ann Med Surg (Lond) | An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. | 2017 | Details |
| A16455 | 28376573 | Aust Fam Physician | The gut microbiome. | 2017 | Details |
| A16457 | 28376109 | PLoS One | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis. | 2017 | Details |
| A16460 | 28375109 | Pak J Pharm Sci | Anti hyperlipidemic and hepatoprotective effects of native date fruit variety "Aseel" (Phoenix dactylifera). | 2016 | Details |
| A16464 | 28372259 | Biomed Pharmacother | Medicinal plants and phytochemicals with anti-obesogenic potentials: A review. | 2017 | Details |
| A16465 | 28371475 | J Diabetes Investig | Impact of non-alcoholic fatty pancreas disease on glucose metabolism. | 2017 | Details |
| A16471 | 28369100 | PLoS One | Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. | 2017 | Details |
| A16475 | 28367184 | Pak J Med Sci | Identification of Metabolic risk phenotypes predisposing to Non-Alcoholic Fatty Liver Disease in a Pakistani Cohort. | 2020 | Details |
| A16476 | 28366357 | J Pediatr | Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. | 2017 | Details |
| A16477 | 28365930 | J BUON | Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment. | 2017 | Details |
| A16479 | 28364816 | Clin Liver Dis | De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. | 2017 | Details |
| A16483 | 28361809 | Ann Ist Super Sanita | Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy. | 2018 | Details |
| A16486 | 28359183 | Expert Opin Drug Metab Toxicol | Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease. | 2017 | Details |
| A16489 | 28358620 | Metab Syndr Relat Disord | Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice. | 2017 | Details |
| A16494 | 28356335 | Pediatrics | Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood. | 2017 | Details |
| A16497 | 28352941 | Diabetologia | EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral? | 2017 | Details |
| A16507 | 28348479 | World J Gastroenterol | Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle. | 2017 | Details |
| A16516 | 28345673 | Sci Rep | Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. | 2017 | Details |
| A16520 | 28341541 | Mol Aspects Med | Pro-resolving actions of SPM in adipose tissue biology. | 2017 | Details |
| A16530 | 28334548 | Appl Physiol Nutr Metab | Waist circumference is associated with liver fat in black and white adolescents. | 2017 | Details |
| A16536 | 28328829 | Medicine (Baltimore) | Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. | 2017 | Details |
| A16537 | 28327588 | Nat Commun | Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. | 2017 | Details |
| A16544 | 28324002 | J Clin Endocrinol Metab | Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly. | 2017 | Details |
| A16547 | 28323124 | J Hepatol | CD44 is a key player in non-alcoholic steatohepatitis. | 2017 | Details |
| A16550 | 28322576 | Child Obes | The Effects of Exercise on Abdominal Fat and Liver Enzymes in Pediatric Obesity: A Systematic Review and Meta-Analysis. | 2017 | Details |
| A16552 | 28319895 | Redox Biol | Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review. | 2017 | Details |
| A16554 | 28319060 | Oncogene | The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. | 2017 | Details |
| A16556 | 28318912 | Diabetes Metab | Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16557 | 28318525 | Actas Dermosifiliogr | Psoriasis and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16558 | 28318371 | Scand J Clin Lab Invest | P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease. | 2017 | Details |
| A16572 | 28299034 | Int J Prev Med | The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients. | 2017 | Details |
| A16574 | 28298942 | J Ultrasound | Liver acoustic radiation force impulse (ARFI) in childhood obesity: comparison and correlation with biochemical markers. | 2016 | Details |
| A16577 | 28298270 | Adv Nutr | Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16583 | 28297798 | Zhonghua Gan Zang Bing Za Zhi | [Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease]. | 2017 | Details |
| A16592 | 28294515 | Liver Int | Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score). | 2017 | Details |
| A16594 | 28293382 | World J Hepatol | Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. | 2017 | Details |
| A16596 | 28293093 | World J Gastroenterol | Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. | 2017 | Details |
| A16597 | 28293086 | World J Gastroenterol | Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma. | 2017 | Details |
| A16600 | 28290049 | Curr Diab Rep | Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. | 2017 | Details |
| A16607 | 28286193 | Clin Gastroenterol Hepatol | In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. | 2017 | Details |
| A16616 | 28281517 | Ter Arkh | [Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency]. | 2017 | Details |
| A16620 | 28281237 | Obes Surg | Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. | 2017 | Details |
| A16627 | 28276821 | Expert Rev Gastroenterol Hepatol | Current and future treatment options in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16634 | 28273479 | Cell Metab | Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine. | 2017 | Details |
| A16636 | 28271632 | IUBMB Life | The role of insufficient copper in lipid synthesis and fatty-liver disease. | 2017 | Details |
| A16638 | 28271032 | Mol Metab | Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. | 2017 | Details |
| A16642 | 28270444 | Am J Physiol Endocrinol Metab | α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats. | 2017 | Details |
| A16647 | 28266792 | J Clin Hypertens (Greenwich) | The science of salt: A regularly updated systematic review of salt and health outcomes (December 2015-March 2016). | 2017 | Details |
| A16649 | 28266614 | Sci Rep | A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. | 2017 | Details |
| A16650 | 28265826 | Dig Dis Sci | Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients. | 2017 | Details |
| A16656 | 28262196 | Arch Med Res | Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. | 2016 | Details |
| A16657 | 28260907 | Ther Clin Risk Manag | Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients. | 2017 | Details |
| A16658 | 28260764 | Mymensingh Med J | Sonographically Detected Non Alcoholic Fatty Liver Disease in Apparently Healthy Adults and Associated Factors. | 2017 | Details |
| A16675 | 28252430 | Georgian Med News | [EATING DISORDERS AND VISCERAL ADIPOSE TISSUE - TWO INTERCONNECTED INFORMATIVE MARKERS OF PROGNOSIS OF DISORDERS OF NUTRITIONAL STATUS AND RISK OF DEVELOPMENT OF COMORBIDITY CHRONIC NON-COMMUNICABLE DISEASES]. | 2017 | Details |
| A16680 | 28249275 | Dig Dis | Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. | 2017 | Details |
| A16681 | 28249273 | Dig Dis | Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation. | 2017 | Details |
| A16686 | 28244519 | Food Funct | A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model. | 2017 | Details |
| A16690 | 28241825 | BMC Med | Non-alcoholic fatty liver disease. | 2017 | Details |
| A16695 | 28239403 | Nutr Metab (Lond) | Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet. | 2017 | Details |
| A16696 | 28239368 | Front Endocrinol (Lausanne) | Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights. | 2017 | Details |
| A16701 | 28235154 | Liver Int | Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study. | 2017 | Details |
| A16702 | 28234943 | PLoS One | High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. | 2017 | Details |
| A16705 | 28232481 | FASEB J | Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance. | 2017 | Details |
| A16707 | 28231800 | Lipids Health Dis | Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. | 2017 | Details |
| A16710 | 28230607 | J Pediatr Gastroenterol Nutr | Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2017 | Details |
| A16711 | 28230324 | Diabetes Obes Metab | Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: Results of a randomized controlled trial using 2 dietary approaches. | 2017 | Details |
| A16712 | 28229316 | Obes Surg | Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16720 | 28223710 | Sci Rep | High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16722 | 28223446 | Diabetes Care | Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16739 | 28214827 | Cell Physiol Biochem | Potential Regulators Driving the Transition in Nonalcoholic Fatty Liver Disease: a Stage-Based View. | 2017 | Details |
| A16740 | 28214524 | Gastroenterology | Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16741 | 28214020 | J Hepatol | Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. | 2017 | Details |
| A16744 | 28212710 | Adv Clin Chem | CTRP1 in Liver Disease. | 2016 | Details |
| A16746 | 28212301 | Mar Drugs | The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH. | 2017 | Details |
| A16749 | 28211165 | Liver Int | A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. | 2017 | Details |
| A16750 | 28211103 | J Neuroendocrinol | Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. | 2017 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16752 | 28209760 | Diabetes | Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. | 2017 | Details |
| A16753 | 28209193 | BMC Complement Altern Med | UP601, a standardized botanical composition composed of Morus alba, Yerba mate and Magnolia officinalis for weight loss. | 2017 | Details |
| A16754 | 28207798 | PLoS One | Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. | 2017 | Details |
| A16756 | 28205519 | Nat Commun | Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance. | 2017 | Details |
| A16757 | 28203453 | Iran Red Crescent Med J | Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A16762 | 28195199 | Sci Rep | Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. | 2017 | Details |
| A16763 | 28195177 | Am J Gastroenterol | Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. | 2017 | Details |
| A16765 | 28194666 | Dig Dis Sci | Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic. | 2017 | Details |
| A16766 | 28194019 | Cell Mol Immunol | IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity. | 2017 | Details |
| A16767 | 28193580 | J Nutr Biochem | Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis. | 2016 | Details |
| A16769 | 28192110 | Gastroenterology | Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians. | 2017 | Details |
| A16773 | 28187366 | J Nutr Biochem | A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A16775 | 28185191 | Methods Mol Biol | A Coupled Approach Utilizing Immunohistochemistry and Immunocytochemistry to Visualize Cellular Lipophagy. | 2017 | Details |
| A16776 | 28184213 | Front Endocrinol (Lausanne) | Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16779 | 28182612 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in HIV Infection. | 2017 | Details |